Transdermal delivery of lornoxicam <i>via</i> transethosomal gel as a novel strategy for management of rheumatoid arthritis
The developed LOR-TES gel enhanced transdermal drug delivery, offering sustained release and improved permeation. It presents a promising strategy for effective management of rheumatoid arthritis through the transdermal route.
Authors
- Salman Khan (ORCID: https://orcid.org/0000-0002-6226-8470)
- Noor Ullah (ORCID: https://orcid.org/0009-0005-5862-1656)
- Kifayat Ullah Shah (ORCID: https://orcid.org/0000-0003-4061-8174)
- Stéphane Gibaud (ORCID: https://orcid.org/0000-0003-3594-0601)
- Moneerah J. Alqahtani (ORCID: https://orcid.org/0000-0003-3013-1354)
- Shefaat Ullah Shah
- Rashna Mirza
- Jawaher Alqahtani
- Doua Ilyas
- Muhammad Ijaz Khan
- Ayesha Muneer
Institutions
- Quaid-i-Azam University (PK)
- Gomal University (PK)
- King Saud University (SA)
- University of Swabi (PK)
- Université de Lorraine (FR)
Publication Details
- Journal
- Drug Development and Industrial Pharmacy
- Published
- 2026-03-05
- DOI
- https://doi.org/10.1080/03639045.2026.2637594
- Primary Topic
- Advancements in Transdermal Drug Delivery
- Type
- article
- Field-Weighted Citation Impact
- 0.00